ctdna
Entity, reached from Hormuz.
- Evidence
- 234 documents · 87 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 9 Oct 2026
- Measured
- 13% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Ann Oncol · 2026-10-07 · Postoperative ctDNA dynamics and eligibility for Treat-on-Molecular Result (TOMR) ALTAIR trial in colorectal cancer: insights from CIRCULATE-Japan. (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-28 · ctDNA Release Heterogeneity in Luminal Breast Cancer Revealed by Single-Cell Multi-Omics Spatial Analysis (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-22 · Explaining and predicting pseudoprogression in immunotherapythrough joint modeling of immune infiltration and ctDNA dynamics (opens the source in a new tab)
- medRxiv Oncology · 2026-09-20 · Methylation-Based ctDNA for Post-Treatment Surveillance of Non-Viral Head and Neck Cancer (opens the source in a new tab)
- J Liq Biopsy · 2026-09-19 · A streamlined hybrid-capture and genome-wide multi-omic platform for highly sensitive ctDNA minimal residual disease monitoring. (opens the source in a new tab)
- J Gastrointest Cancer · 2026-09-16 · Postoperative ctDNA-Guided Adjuvant Therapy in Resected Colorectal Cancer: A Systematic Review and Meta-analysis of Prognostic Validity Versus Treatment-Decision … (opens the source in a new tab)
- Onco Targets Ther · 2026-09-15 · ctDNA in the Management of Resectable & Advanced Colorectal Cancer: Current Status and Future Directions. (opens the source in a new tab)
- JCO Precision Oncology · 2026-09-13 · Relative Mutant Allele Frequency Role in ctDNA-Guided Anti–Epidermal Growth Factor Receptor Rechallenge in Metastatic Colorectal Cancer (opens the source in a new tab)
- European Journal of Cancer · 2026-09-13 · High-dose furmonertinib plus bevacizumab and intrathecal pemetrexed for EGFR-RAD51 fusion-positive lung adenocarcinoma with leptomeningeal metastasis: Insigh… (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with colorectal cancer (125 documents)seen together
- co-mentioned with immunotherapy (39 documents)seen together
- co-mentioned with fda (37 documents)seen together
- co-mentioned with breast cancer (34 documents)seen together
- co-mentioned with ai (30 documents)seen together
- co-mentioned with lung cancer (28 documents)seen together
- co-mentioned with united states (25 documents)seen together
- co-mentioned with solid tumors (22 documents)seen together
- co-mentioned with her2 (22 documents)seen together
- co-mentioned with t-cell (21 documents)seen together